GUESF yields 2000000.00% · JNJ yields 2.13%● Live data
📍 GUESF pulled ahead of the other in Year 1
Combined, GUESF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GUESF + JNJ for your $10,000?
GuestLogix Inc. provides retail and payment technology solutions to the passenger travel industry. The company offers point-of-sale (POS) hardware solutions comprising mobile, POS device, and inflight entertainment systems; retail platform solutions; and payment processing technology, as well as OnTouch destination merchandising solutions. It also provides ancillary insights services, such as out-of-the-box reporting suites, enterprise reporting toolsets, and advanced analytics; and travel retail performance management services consisting of operational process development, outsourced retail management, and retail model development services. In addition, the company offers GuestPass Ticketing, a ticketing solution that enables travel operators to facilitate ticketing services across multiple access points; and t-Retail Platform, which provides destination-based content for travel operators to use in the booking path. It primarily serves customers in North America, Europe, South America, Africa, and Asia. The company is headquartered in Toronto, Canada.
Full GUESF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.